Literature DB >> 7281898

[Intracellular effect of hydroxyalkenals on animal tumors (author's transl)].

G Khoschsorur, R J Schaur, E Schauenstein, H M Tillian, M Reiter.   

Abstract

When incubated for 30 min in vitro, 4-hydroxyalkenals in a 5 x 10-3 M solution react with SH-groups of soluble cytoplasmic and nuclear proteins (ProtL-SH) of Morris hepatomas 9618 A and 5123 tc, and of Ehrlich ascites tumor (EAT) cells. The extent of the reaction strongly increases with decreasing doubling time of the respective tumors. Former experiments with EAT cells have shown that the reaction with cytoplasmic ProtL-SH causes inhibition of respiration, glycolysis, and probably of other SH-controlled processes associated with cell division. The intranuclear reaction leads to an inhibition of DNA- and RNA-synthesis. In a 2 x 10-4 M solution of hydroxyalkenals, however, the reaction with cytoplasmic ProtL-SH diminishes almost completely so that no measurable inhibition of respiration and only 3% inhibition of glycolysis are observed, while 20 to 30 percent of the nuclear ProtL-SH are still blocked. This corresponds well with a previous observation that a 2 x 10-4 M solution of hydroxypentenal inhibits DNA-synthesis by 90 percent.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7281898

Source DB:  PubMed          Journal:  Z Naturforsch C Biosci        ISSN: 0341-0382


  3 in total

Review 1.  Novel aspect of chemophototherapy in treatment of cancer.

Authors:  Sandesh Chibber; Mohd Farhan; Iftekhar Hassan; Imrana Naseem
Journal:  Tumour Biol       Date:  2011-12-22

2.  Iron-induced lipid peroxidation and inhibition of proliferation in Ehrlich ascites tumor cells.

Authors:  H M Tillian; A Hammer; E Kink; R J Schaur; E Schauenstein
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

3.  Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1.

Authors:  Y Shao; L Pardini; R S Pardini
Journal:  Lipids       Date:  1995-11       Impact factor: 1.880

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.